Institutional investors purchased a net $2.5 million shares of DXCM during the quarter ended June 2014 and now own 97.78% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FEDERATED GLOBAL INVESTMENT MANA... Bought 4.0 Million shares of DexCom Inc
WELLINGTON MANAGEMENT CO. LLP Bought 1.7 Million shares of DexCom Inc
T. ROWE PRICE ASSOCIATES, INC. Bought 1.2 Million shares of DexCom Inc